BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 9635296)

  • 21. Mutation analysis of 28 Gaucher disease patients: the Australasian experience.
    Lewis BD; Nelson PV; Robertson EF; Morris CP
    Am J Med Genet; 1994 Jan; 49(2):218-23. PubMed ID: 8116672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional characterization of the novel mutation IVS 8 (-11delC) (-14T>A) in the intron 8 of the glucocerebrosidase gene of two Italian siblings with Gaucher disease type I.
    Romano M; Danek GM; Baralle FE; Mazzotti R; Filocamo M
    Blood Cells Mol Dis; 2000 Jun; 26(3):171-6. PubMed ID: 10950936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P).
    Brown JT; Lahey C; Laosinchai-Wolf W; Hadd AG
    BMC Med Genet; 2006 Aug; 7():69. PubMed ID: 16887033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation prevalence among 51 unrelated Spanish patients with Gaucher disease: identification of 11 novel mutations.
    Alfonso P; Cenarro A; Pérez-Calvo JI; Giralt M; Giraldo P; Pocoví M
    Blood Cells Mol Dis; 2001; 27(5):882-91. PubMed ID: 11783951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gaucher disease with prenatal onset and perinatal death due to compound heterozygosity for the missense R131C and null Rec Nci I GBA mutations.
    Goebl A; Ferrier RA; Ferreira P; Pinto-Rojas A; Matshes E; Choy FY
    Pediatr Dev Pathol; 2011; 14(3):240-3. PubMed ID: 20946052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 55-base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles.
    Tayebi N; Stern H; Dymarskaia I; Herman J; Sidransky E
    Am J Med Genet; 1996 Dec; 66(3):316-9. PubMed ID: 8985494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a 55-bp deletion in the glucocerebrosidase gene in Gaucher disease: phenotypic presentation and implications for mutation detection assays.
    Mao R; O'Brien JF; Rao S; Schmitt E; Roa B; Feldman GL; Spence WC; Snow K
    Mol Genet Metab; 2001 Mar; 72(3):248-53. PubMed ID: 11243731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of Gaucher disease: screening of patients in the Montreal/Quebec region.
    Choy FY; Woo M; Der Kaloustian VM
    Am J Med Genet; 1991 Dec; 41(4):469-74. PubMed ID: 1776640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocerebrosidase recombinant allele: molecular evolution of the glucocerebrosidase gene and pseudogene in primates.
    Wafaei JR; Choy FY
    Blood Cells Mol Dis; 2005; 35(2):277-85. PubMed ID: 16102985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliable co-segregation analysis for prenatal diagnosis and heterozygote detection in Gaucher disease.
    Cormand B; Montfort M; Chabás A; Grinberg D; Vilageliu LL
    Prenat Diagn; 1998 Mar; 18(3):207-12. PubMed ID: 9556036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
    Koprivica V; Stone DL; Park JK; Callahan M; Frisch A; Cohen IJ; Tayebi N; Sidransky E
    Am J Hum Genet; 2000 Jun; 66(6):1777-86. PubMed ID: 10796875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype?
    Sidransky E; Bottler A; Stubblefield B; Ginns EI
    Hum Mutat; 1994; 3(1):25-8. PubMed ID: 8118463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
    Hruska KS; LaMarca ME; Scott CR; Sidransky E
    Hum Mutat; 2008 May; 29(5):567-83. PubMed ID: 18338393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations.
    Pomponio RJ; Cabrera-Salazar MA; Echeverri OY; Miller G; Barrera LA
    Mol Genet Metab; 2005 Dec; 86(4):466-72. PubMed ID: 16185907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of six new Gaucher disease mutations.
    Beutler E; Gelbart T; West C
    Genomics; 1993 Jan; 15(1):203-5. PubMed ID: 8432537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome.
    Cormand B; Grinberg D; Gort L; Chabás A; Vilageliu L
    Hum Mutat; 1998; 11(4):295-305. PubMed ID: 9554746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gaucher disease: clinical, genetic and therapeutic aspects].
    Germain DP
    Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?
    Stone DL; van Diggelen OP; de Klerk JB; Gaillard JL; Niermeijer MF; Willemsen R; Tayebi N; Sidransky E
    Eur J Hum Genet; 1999; 7(4):505-9. PubMed ID: 10352942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
    Sobreira E; Pires RF; Cizmarik M; Grabowski GA
    Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and functional characterization of five novel mutant alleles in 58 Italian patients with Gaucher disease type 1.
    Miocić S; Filocamo M; Dominissini S; Montalvo AL; Vlahovicek K; Deganuto M; Mazzotti R; Cariati R; Bembi B; Pittis MG
    Hum Mutat; 2005 Jan; 25(1):100. PubMed ID: 15605411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.